Evidence map›Paper›PMID 32284758›Full record

ReviewJournal of Cancer2020

Deep Learning Model as a New Trend in Computer-aided Diagnosis of Tumor Pathology for Lung Cancer.

Lei Cong, Wanbing Feng, Zhigang Yao, Xiaoming Zhou, Wei Xiao

Abstract readReview
In one paragraph

Review in Journal of Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. [Prediction of recurrence-free survival in lung adenocarcinoma based on self-supervised pre-training and multi-task learning].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Artificial intelligence and computational pathology.Laboratory investigation; a journal of technical methods and pathology · 2021
    Review
  18. Article
  19. A bird's-eye view of deep learning in bioimage analysis.Computational and structural biotechnology journal · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lei CongDepartment of Oncology, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China.
Wanbing FengCheeloo College of Medicine, Shandong University, Jinan, China.
Zhigang YaoDepartment of Pathology, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China.
Xiaoming ZhouDepartment of Scientific Research, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China.
Wei XiaoDepartment of Scientific Research, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer is one of the main causes of cancer-related death in the world. The identification and characteristics of malignant cells are essential for the diagnosis and treatment of primary or metastatic cancers. Deep learning is a new field of artificial intelligence, which can be used for computer aided diagnosis and scientific research of lung cancer pathology by analyzing and learning through establishment and simulation of human brain. In this review, we will introduce the application, progress and problems of deep learning in pathology of lung cancer and make prospects for its future development.

Indexed as

artificial intelligencedeep learninglung cancerpathology

Identifiers

PMID32284758
PMCPMC7150458

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.